Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification-Reference-Cited by-同舟云学术

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification

Published:2015-09-28 Issue:3 Volume:20 Page:425-432
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Hirano Keita,Amano Hoichi,Kawamura Tetsuya,Watanabe Kyoko,Koike Kentaro,Shimizu Akihiro,Endo Satoshi,Tsuboi Nobuo,Okonogi Hideo,Miyazaki Yoichi,Ikeda Masato,Hanaoka Kazushige,Ogura Makoto,Komatsumoto Satoru,Yokoo Takashi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-015-1170-7.pdf

Reference19 articles.

1. D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.

2. KDIGO clinical practice guidelines for glomerulonephritis—chapter 10: immunoglobulin A nephropathy. Kidney Int Suppl. 2012;2:209–17.

3. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353:883–7.

4. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.

5. Reich HN, Troyanov S, Scholey JW, Cattran DC. Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177–83.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence of crescentic IgA nephropathy 3 years after successful treatment;Clinical Nephrology;2024-04-01

2. Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis;Clinical Kidney Journal;2023-12

3. Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy;Biomedicines;2022-11-24

4. How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies;Pediatric Nephrology;2022-08-02

5. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy;Clinical and Experimental Nephrology;2022-04-15